查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1575773

全球 Omega-3 PUFA 市場 - 2024-2031

Global Omega-3 PUFA Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 219 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023 年，全球 omega-3 PUFA 市場達到 24 億美元，預計到 2031 年將達到 44 億美元，2024-2031 年預測期間複合年成長率為 7.9%。

由於消費者意識的不斷增強以及對改善健康的營養素的需求，Omega-3 多元不飽和脂肪酸 (PUFA) 市場正在迅速擴大。關鍵的Omega-3 脂肪酸，包括α-亞麻油酸(ALA)、二十碳五烯酸(EPA) 和二十二碳六烯酸(DHA)，因其抗發炎、心血管和認知功效而受到重視。全球可支配收入的增加，特別是在亞洲等發展中經濟體，健康意識不斷增強的消費者行為正在增加，支持了這一趨勢。

最近的趨勢顯示 Omega-3 來源和產品日益多樣化。 Omega-3 傳統上源自富含脂肪的魚類，現在有多種形式可供選擇，包括亞麻仁油和奇亞籽油等植物替代品，以滿足純素食和素食消費者的需求。此外，基於藻類的補充劑的進步擴大了市場供應，為獲取這些必需營養素提供了更多選擇。這種多樣化符合將健康益處融入日常食品和補充劑的更廣泛趨勢。

2023 年 9 月，全球藻類飼料成分領導者 Corbion 推出了 AlgaPrime DHA P3，這是一種突破性的 omega-3 成分，旨在增強寵物食品營養。該新產品顯著提高了 DHA（二十二碳六烯酸）水平，提供了一種高性能解決方案，可減少對海洋資源的依賴並降低寵物食品的碳足跡。

市場動態

嬰兒營養的需求不斷增加

《當前營養發展》中的這項研究著眼於母親在懷孕期間服用二十二碳六烯酸 (DHA) 時嬰兒的身體組成會發生什麼變化。具體來說，該研究著眼於脂肪量（FM）和妊娠期體重增加（GWG）。新生兒生長和肥胖研究 (GAINS) 包括 ADORE 試驗中的 250 名受試者，結果發現產前 DHA 會增加嬰兒脂肪量，而不會改變母親的 GWG。結果在不同性別之間是一致的，並且在 24 個月的追蹤中持續存在，這表明需要進一步研究長期影響。

對嬰兒營養的需求不斷增加，特別是在 omega-3 多元不飽和脂肪酸 (PUFA) 領域，反映出人們對產前營養重要性的認知不斷增強。隨著越來越多的證據表明 Omega-3 PUFA（例如 DHA）對嬰兒脂肪分佈和整體身體組成的益處，人們開始顯著轉向加強產前飲食干預。在消費者和醫療保健提供者對從早期階段最佳化嬰兒健康的興趣推動下，市場對富含 DHA 的補充劑的需求增加。

越來越多的證據表明 DHA 如何降低兒童肥胖風險並改善嬰兒健康狀況，導致 omega-3 PUFA 補充劑市場不斷成長。這一趨勢與更廣泛的預防性健康措施和個人化營養策略運動一致。隨著正在進行的研究不斷驗證 omega-3 PUFA 的益處，對此類補充劑的需求預計將成長，從而促進該行業的創新和增加投資。

消費者越來越意識到 Omega-3 PUFA 的健康益處

消費者對 omega-3 多元不飽和脂肪酸 (PUFA) 相關健康益處的認知不斷增強，推動了 omega-3 PUFA 市場的成長。 Omega-3 PUFA，包括二十碳五烯酸 (EPA) 和二十二碳六烯酸 (DHA)，因其在減少發炎、增強心血管健康和支持認知功能方面的作用而廣受好評。意識的提高正在影響消費者的偏好和行為，特別是對於尋求透過膳食補充劑來提高表現和恢復的運動員和具有健康意識的個人。

隨著越來越多的人尋求將這些有益脂肪納入飲食中，omega-3 PUFA 的市場正在擴大。人們越來越認知到 omega-3 對健康的正面影響、減少發炎的功效以及改善運動表現和恢復的潛力，這是這一趨勢的促進因素。因此，富含 omega-3 PUFA 的補充劑和功能性食品的市場不斷成長，滿足了消費者對健康促進產品不斷成長的需求。

永續性和環境議題

二十碳五烯酸(EPA)、二十二碳五烯酸(DPA) 和二十二碳六烯酸(DHA) 是三種重要的omega-3 長鏈多元不飽和脂肪酸(LC-PUFA) ，對人類健康和營養非常重要。傳統上，這些營養物質來自海魚、磷蝦和藻類。然而，這些海洋資源的可用性要么停滯不前，要么正在下降，帶來了重大的永續性挑戰。

根據 MDPI，為了滿足對 ω3 LC-PUFA 不斷成長的需求而過度捕撈野生海洋物種已導致嚴重的環境影響。此外，到 2100 年，氣候變遷可能導致全球 DHA 水準下降 10% 至 58%，這主要是由於微藻的可用性減少，而微藻是海洋食物鏈中 ω3 LC-PUFA 的基本來源。這種情況加劇了海洋生態系統的壓力，並導致魚類資源減少。

水產養殖提供了 ω3 LC-PUFA 野生捕撈的替代方案，但它取決於這些營養物質的永續供應。養殖魚類對海洋 ω3 LC-PUFA 來源的依賴限制了水產養殖有效解決野生魚類族群枯竭問題的潛力。因此，其營養來源的可用性和環境影響限制了水產養殖的永續性。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 嬰兒營養的需求不斷增加
      • 消費者越來越認知到 omega-3 PUFA 的健康益處
    • 限制
      • 永續性和環境議題
  • 機會
  • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：按來源

  • 海洋資源
    • 魚油
    • 磷蝦油
    • 海藻油
    • 其他油類
  • 植物來源
    • 亞麻仁油
    • 奇亞籽油
    • 大麻油
    • 其他油類

第 7 章：按類型

  • α-亞麻油酸 (ALA)
  • 二十二碳六烯酸 (DHA)
  • 二十碳五烯酸 (EPA)

第 8 章：按申請

  • 食品和飲料
  • 膳食補充劑
  • 藥品
  • 其他應用

第 9 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • Cargill, Incorporated.
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • DSM
  • Corbion
  • Croda International Plc
  • ADM
  • Arista Industries, Inc.
  • Omega Protein Corporation
  • Goerlich Pharma GmbH
  • Evonik
  • Nu-Mega Ingredients (*LIST NOT EXHAUSTIVE)

第 12 章：附錄

簡介目錄
Product Code: FB553

Overview

Global omega-3 PUFA Market reached US$ 2.4 billion in 2023 and is expected to reach US$ 4.4 billion by 2031, growing with a CAGR of 7.9% during the forecast period 2024-2031.

Due to growing consumer awareness and demand for nutrients that improve health, the Omega-3 Polyunsaturated Fatty Acids (PUFAs) market is expanding rapidly. Key Omega-3s, including Alpha-Linolenic Acid (ALA), Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA), are valued for their anti-inflammatory, cardiovascular and cognitive benefits. Increased disposable incomes worldwide, particularly in developing economies like Asia where health-conscious consumer behavior is on the rise, are supporting the trend.

Recent trends indicate a growing diversification in Omega-3 sources and products. Traditionally sourced from fatty fish, Omega-3s are now available in a variety of forms, including plant-based alternatives like flaxseed and chia seed oils, catering to vegan and vegetarian consumers. Furthermore, advancements in algae-based supplements have broadened market offerings, providing additional options for obtaining these essential nutrients. The diversification aligns with the broader trend of incorporating health benefits into everyday foods and supplements.

In September 2023, Corbion, a global leader in algae-based feed ingredients, introduced AlgaPrime DHA P3, a groundbreaking omega-3 ingredient designed to enhance pet food nutrition. The new product significantly boosts DHA (docosahexaenoic acid) levels, offering a high-performance solution that reduces reliance on marine sources and lowers the carbon footprint of pet food products.

Market Dynamics

Increasing Demand for Infant Nutrition

The study in Current Developments in Nutrition looks at what happens to a baby's body composition when docosahexaenoic acid (DHA) is given to the mother during pregnancy. Specifically, the study looks at fat mass (FM) and gestational weight gain (GWG). The Growth and Adiposity in Newborns Study (GAINS), which included 250 people from the ADORE trial, found that prenatal DHA increases baby fat mass by a lot without changing the GWG of the mother. The results were consistent across sexes and persisted through a 24-month follow-up, reinforcing the need for further research on long-term effects.

The increasing demand for infant nutrition, particularly in the omega-3 polyunsaturated fatty acids (PUFA) sector, reflects a growing awareness of the importance of prenatal nutrition. As evidence mounts regarding the benefits of omega-3 PUFAs, such as DHA, on infant fat distribution and overall body composition, there is a notable shift towards enhancing prenatal dietary interventions. It has resulted in an increased market demand for DHA-enriched supplements, driven by both consumer and healthcare provider interest in optimizing infant health from an early stage.

The growing body of evidence showing how DHA reduces the risk of childhood obesity and improves infant health outcomes is causing the market for omega-3 PUFA supplements to grow. The trend aligns with a broader movement towards preventative health measures and personalized nutrition strategies. As ongoing studies continue to validate the benefits of omega-3 PUFAs, the demand for such supplements is expected to grow, prompting innovation and increased investment in the sector.

Growing Consumer Awareness Of The Health Benefits Of Omega-3 PUFAs

Consumer awareness of the health benefits associated with omega-3 polyunsaturated fatty acids (PUFAs) has been increasing, driving growth in the omega-3 PUFA market. Omega-3 PUFAs, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are well-regarded for their roles in reducing inflammation, enhancing cardiovascular health and supporting cognitive function. Increased awareness is influencing consumer preferences and behaviors, particularly among athletes and health-conscious individuals seeking to improve performance and recovery through dietary supplements.

The market for omega-3 PUFAs is expanding as more individuals seek to incorporate these beneficial fats into their diets. Increased awareness of omega-3s' positive effects on health, their efficacy in reducing inflammation, and their potential to improve athletic performance and recovery are the trends driving factors. As a result, there is a growing market for supplements and functional foods enriched with omega-3 PUFAs, catering to the rising consumer demand for health-promoting products.

Sustainability and Environmental Concerns

Eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) are three important omega-3 long-chain polyunsaturated fatty acids (LC-PUFA) that are very important for human health and nutrition. Traditionally, these nutrients are sourced from marine fish, krill and algae. However, the availability of these marine resources is either stagnant or on the decline, presenting significant sustainability challenges.

As per MDPI, the overfishing of wild marine species to meet the growing demand for ω3 LC-PUFA has led to substantial environmental impacts. Furthermore, climate change threatens to diminish global DHA levels by 10 to 58% by 2100, primarily due to the reduced availability of microalgae, the fundamental source of ω3 LC-PUFA in the marine food chain. The situation exacerbates the strain on marine ecosystems and contributes to the decline of fish stocks.

Aquaculture offers an alternative to wild fishing for ω3 LC-PUFA, yet it depends on the sustainable provision of these nutrients. The reliance on marine-based ω3 LC-PUFA sources for farmed fish limits the potential of aquaculture to address the depletion of wild fish populations effectively. Thus, the availability and environmental impact of its nutrient sources limit the sustainability of aquaculture.

Segment Analysis

The global omega-3 PUFA market is segmented based on source, type, application and region.

The Surging Demand for Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)

News Medical Life Sciences reports that a new study on omega-3 fatty acids, specifically docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), shows that they may help treat acne. This is in line with a larger trend of rising consumer demand for these compounds. Research highlights the anti-inflammatory properties of DHA and EPA, showing that these omega-3 fatty acids may help reduce acne severity. It aligns with the growing consumer awareness of the health benefits of omega-3 fatty acids, which is driving increased demand for these ingredients in dietary supplements and functional foods.

In addition, the study's findings on the efficacy of DHA and EPA in treating acne contribute to the expanding applications of these fatty acids in dermatology and skincare. The evidence supporting the use of DHA and EPA for skin health is fueling market growth as consumers seek products that offer these benefits. The trend is part of a broader movement towards preventive health and wellness, with individuals increasingly turning to dietary supplements to support overall well-being, including skin health.

Geographical Penetration

Rising Demand for Omega-3 PUFA in North America

North America is expected to be the dominant region in the global omega-3 PUFA market holding an approximate market share of 35% during the forecast period. The partnership between DSM-Firmenich and SCN BestCo represents a pivotal moment in the evolution of omega-3 polyunsaturated fatty acids (PUFAs) within the North American market. Fish oil soft gels have historically dominated the market, but despite their effectiveness, they came with drawbacks like a fishy aftertaste, large capsule size, and environmental issues related to overfishing.

As consumer awareness of omega-3 benefits for heart health, cognitive function and overall wellness grew, so did the demand for more palatable and sustainable alternatives. In response to increasing consumer demand for plant-based and environmentally friendly options, the market began to shift towards algal-based omega-3 supplements. The products offered a sustainable, vegetarian-friendly alternative to traditional fish oil, addressing concerns about overfishing and the ecological impact of omega-3 production.

In March 2024, the collaboration between dsm-Firmenich and SCN BestCo is a direct response to these evolving consumer preferences. By leveraging dsm-Firmenich's life's OMEGA O33-P100, an algal-based omega-3 powder, the partnership has successfully developed high-load omega-3 gummies. The gummies provide over 400 mg of EPA and DHA per two-piece serving, significantly surpassing the typical dosage levels found in traditional omega-3 gummies.

Competitive Landscape

The major global players in the market include Cargill, Incorporated, DSM, Corbion, Croda International Plc, ADM, Arista Industries, Inc., Omega Protein Corporation, Goerlich Pharma GmbH, Evonik and Nu-Mega Ingredients.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has significantly impacted the omega-3 polyunsaturated fatty acids (PUFA) market. The conflict has disrupted supply chains and increased production costs due to rising prices of raw materials and logistics challenges. The war has also led to economic instability in the region, affecting consumer purchasing power and demand for omega-3 PUFA products.

Furthermore, the sanctions imposed on Russia have complicated trade relationships, limiting access to key markets and affecting the overall availability of omega-3 PUFA products in the region. As a result, the market is experiencing uncertainty and volatility, with companies needing to adapt to the rapidly changing geopolitical landscape.

By Source

Marine Sources

Fish Oil

Krill Oil

Algae Oil

Other Oils

Plant Sources

Flaxseed Oil

Chia Seed Oil

Hemp Oil

Other Oils

By Type

Alpha linoleic acid (ALA)

Docosahexaenoic acid (DHA)

Eicosapentaenoic acid (EPA)

By Application

Food and Beverages

Dietary Supplements

Pharmaceuticals

Other Applications

By Region

North America

US

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In April 2024, FrieslandCampina introduced two innovative DHA ingredients, Biotis DHA FlexP 15 and Biotis DHA FlexP 20, tailored for the adult nutrition market. The high-load, algae-based, microencapsulated DHA powders are designed for vegan and vegetarian formulations, offering exceptional sensory qualities.

In March 2024, Epax introduced EPAX Omega 3-9-11, the first concentrated oil combining long-chain monounsaturated fatty acids (LC-MUFAs) and long-chain polyunsaturated fatty acids (LC-PUFAs), derived from North Atlantic pelagic fish. The innovative product, rich in Omega-3 (EPA and DHA), Omega-9 and Omega-11 is developed using Epax EQP+ Tech, a specialized distillation process enhancing fatty acid content.

In January 2024, Ritual introduced its Omega-3 DHA + EPA supplement, offering a 500 mg dose of omega-3 fatty acids in a 2:1 DHA to EPA ratio. Sourced sustainably from microalgae in La Foret-Fouesnant, France, the supplement is produced using patented technology to minimize oxidation and reduce burp-back, with natural citrus oil added for improved taste.

Why Purchase the Report?

To visualize the global omega-3 PUFA market segmentation based on source, type, application and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the omega-3 PUFA market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global omega-3 PUFA market report would provide approximately 62 tables, 53 figures and 219 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Demand for Infant Nutrition
      • 4.1.1.2. Growing consumer awareness of the health benefits of omega-3 PUFAs
    • 4.1.2. Restraints
      • 4.1.2.1. Sustainability and Environmental Concerns
  • 4.2. Opportunity
  • 4.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. By Source

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 6.1.2. Market Attractiveness Index, By Source
  • 6.2. Marine Sources*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Fish Oil
    • 6.2.4. Krill Oil
    • 6.2.5. Algae Oil
    • 6.2.6. Other Oils
  • 6.3. Plant Sources
    • 6.3.1. Flaxseed Oil
    • 6.3.2. Chia Seed Oil
    • 6.3.3. Hemp Oil
    • 6.3.4. Other Oils

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Alpha linoleic acid (ALA)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Docosahexaenoic acid (DHA)
  • 7.4. Eicosapentaenoic acid (EPA)

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Food and Beverages*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Dietary Supplements
  • 8.4. Pharmaceuticals
  • 8.5. Other Applications

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. US
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Cargill, Incorporated.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. DSM
  • 11.3. Corbion
  • 11.4. Croda International Plc
  • 11.5. ADM
  • 11.6. Arista Industries, Inc.
  • 11.7. Omega Protein Corporation
  • 11.8. Goerlich Pharma GmbH
  • 11.9. Evonik
  • 11.10. Nu-Mega Ingredients (*LIST NOT EXHAUSTIVE)

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us